Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
BMC Psychiatry|June 6, 2022
Reasons for treatment changes in adults with attention-deficit/hyperactivity disorder: a chart review studyJeff Schein, Ann Childress, Martin Cloutier, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 8, 2008
Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorderRaul R Silva, Rafael Muniz, Linda Pestreich, et al.
BMC Psychiatry|September 16, 2024
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United StatesChristian Liman, Jeffrey Schein, Ashley Wu, et al.
Journal of Child and Adolescent Psychopharmacology|June 20, 2023
d-Amphetamine Transdermal System in Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Secondary Endpoint Results and <i>Post Hoc</i> Effect Size Analyses from a Pivotal TrialAndrew J Cutler, Katsumi Suzuki, Brittney Starling, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 2, 2025
A Matching-Adjusted Indirect Comparison (MAIC) of Centanafadine versus Methylphenidate Hydrochloride in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): Short-Term Safety and Efficacy Outcomes: Comparaison indirecte ajustée par appariement (MAIC) entre centanafadine et le chlorhydrate de méthylphénidate chez les adultes atteints d'un trouble déficitaire de l'attention avec ou sans hyperactivité (TDAH) : Résultats en matière d'innocuité et d'efficacité à court termeJeff Schein, Maryaline Catillon, Chunyi Xu, et al.
BMC Psychiatry|August 18, 2022
Treatment patterns among children and adolescents with attention-deficit/hyperactivity disorder in the United States - a retrospective claims analysisJeff Schein, Ann Childress, Julie Adams, et al.
Neurology and Therapy|November 16, 2024
Treatment Preferences of Physicians Treating Adult Patients with Attention-Deficit/Hyperactivity Disorder in the United States and Canada: A Discrete Choice ExperimentJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.
Patient Preference and Adherence|August 12, 2024
Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder - A Discrete Choice ExperimentJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.
Journal of Comparative Effectiveness Research|August 12, 2024
A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperactivity disorder: long-term safety and efficacyJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.
Child and Adolescent Psychiatry and Mental Health|July 8, 2024
Healthcare resource utilization and costs associated with psychiatric comorbidities in pediatric patients with attention-deficit/hyperactivity disorder: a claims-based case-cohort studyJeff Schein, Martin Cloutier, Marjolaine Gauthier-Loiselle, et al.
Pageof 8